Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.indianpharmapost.com/news/astrazeneca-completes-equity-investment-agreement-with-cellectis-15615
https://www.astrazeneca.com/media-centre/press-releases/2024/astrazeneca-completes-cellectis-equity-investment.html
https://www.globenewswire.com/news-release/2024/05/06/2875525/0/en/Cellectis-Announces-Completion-of-the-Additional-Equity-Investment-by-AstraZeneca.html
https://www.globenewswire.com/news-release/2024/05/02/2874768/0/en/Cellectis-Appoints-Arthur-Stril-as-Interim-Chief-Financial-Officer.html
https://www.globenewswire.com/news-release/2024/04/29/2871677/0/en/Cellectis-Reports-Financial-Results-for-the-Fourth-Quarter-and-Full-Year-2023.html
https://www.globenewswire.com/news-release/2024/04/22/2867231/0/en/Cellectis-Presents-Novel-TALEN-Editing-Processes-Enabling-Highly-Efficient-Gene-Correction-and-Gene-Insertion-in-HSPCs.html
https://www.globenewswire.com/news-release/2024/04/10/2861129/0/en/Cellectis-Publishes-a-Novel-Intronic-Gene-Editing-Approach-For-the-Treatment-of-Inborn-Metabolic-Diseases-by-Edited-HSPCs.html
https://www.globenewswire.com/news-release/2024/04/08/2859598/0/en/Cellectis-Announces-Two-Poster-Presentations-on-Novel-TALEN-Editing-Process-for-Gene-Correction-and-Gene-Insertion-in-HSPCs-at-the-ASGCT-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/04/2858222/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html
https://www.globenewswire.com//news-release/2024/03/04/2839998/0/en/Monthly-information-on-share-capital-and-company-voting-rights.html